Dr Hervé Barjat
Following undergraduate studies in chemistry at Université Claude Bernard in Lyon, and an M.Sc. in physical methods of chemical analysis at UEA, he specialised in NMR spectroscopy whilst studying for a PhD at the University of Manchester with Prof. Gareth Morris. He developed novel data acquisition methods as well as analysis tools in high-field liquid-state […]
Dr Ekta Patel
Ekta is responsible for the management of the Psychiatry Consortium. Ekta is a translational scientist with over 8 years of drug discovery research experience in both academic and industrial roles. Combining her scientific knowledge and experience of working across SMEs, academic research groups and pharmaceutical companies, Ekta provides in-depth support to our collaborators to develop […]
Dr Kirsty Winn
Kirsty Winn is a cell biologist and pharmacologist experienced in early drug discovery and lead generation. Kirsty joined MDC in 2020 as an External Drug Discovery Project Lead; responsible for providing drug discovery advice, scientific due diligence and robust research plans alongside UK medicines discovery innovators. Prior to MDC Kirsty led integrated drug discovery programmes […]
Sarah Brockbank
Sarah Brockbank leads the strategy for Complex Medicines at Medicines Discovery Catapult. In this role she draws on internal expertise and the external environment, through membership of national programmes and a portfolio of client projects, to develop and implement a core strategy for complex medicines that is responsive to the needs of this emerging area. […]
Dr Graeme Wilkinson
Graeme is Head of Virtual R&D at Medicines Discovery Catapult. A pharmacologist by training, and with over 25 years of experience in the industry, Graeme has a track record of successfully leading drug discovery and capability enhancement projects in large pharma and start-up across many disease areas. In addition, Graeme has also significant experience in […]
Dr Benedetta Arno
Benedetta is an expert scientist, with over 10 years of research experience within academia and industry. She has experience in leading in vivo drug discovery projects, with the main focus on characterising complex medicines distribution and efficacy using a broad range of imaging modalities including PET, CT, optical imaging and ultrasound as well as ex […]
Dr Michael Fairclough
Michael has worked in the field of PET radiochemistry for over 15 years, obtaining his PhD in radiochemistry from the University of Manchester focussing on PET radiochemistry for the investigation of pain and inflammation. Michael also holds an honorary lecture position at the University of Manchester teaching basic and advanced PET radiochemistry theory for MSc […]
Robert Sherville-Payne
With a professional legal and compliance background and over 25 years of commercial experience, Robert brings significant expertise as a solicitor to his role as General Counsel and Company Secretary at Medicines Discovery Catapult. Having trained and worked at law firm Hogan Lovells in London, Robert spent 14 years at AstraZeneca in a range of […]
Dr Lauren Toms
Lauren is a Scientist in Single Molecule Localisation Microscopy (SMLM) with over six years’ of experience using and optimising super-resolution microscopy techniques. Lauren has a PhD from the University of Manchester, where she used advanced microscopy to investigate the ultrastructure of proteins in cardiac myocytes in health and heart failure. At Medicines Discovery Catapult, Lauren […]